MODIFICATION
B -- Study to Investigate the Sensitivity of Pharmacokinetics in Detecting Differences in Physicochemical Properties of the Active in Suspension Nasal Products for Local Action
- Notice Date
- 8/28/2013
- Notice Type
- Modification/Amendment
- NAICS
- 541712
— Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, 5630 Fishers Lane, Room 2129, Rockville, Maryland, 20857-0001
- ZIP Code
- 20857-0001
- Solicitation Number
- FDA-SOL-1120918
- Archive Date
- 9/25/2013
- Point of Contact
- Tomeka Evans, Phone: 3018277168
- E-Mail Address
-
Tomeka.Evans@fda.hhs.gov
(Tomeka.Evans@fda.hhs.gov)
- Small Business Set-Aside
- N/A
- Description
- Note: The due date is hereby extended to September 10, 2013 at 1:00 pm ET. Please see attachments to view this combined synopsis/solicitation in its entirety. This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested and a written solicitation will not be issued. Solicitation FDA-SOL-1120918 is being issued as a Request for Quotation (RFQ). The solicitation and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2005-69. This requirement is being solicited under full and open competition using Simplified Acquisition Procedures per FAR Subpart 13.5. The associated North American Industrial Classification System (NAICS) code for this procurement is 541712, with a small business size standard of 500 employees. The U. S. Food & Drug Administration (FDA), Office of Acquisitions and Grant Services (OAGS) is seeking to purchase a study to investigate the sensitivity of pharmacokinetics in detecting differences in physicochemical properties of the active in suspension nasal products for local action.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/DCASC/FDA-SOL-1120918/listing.html)
- Place of Performance
- Address: The Place of Performance will primarily be at the Contractor's location., United States
- Record
- SN03165292-W 20130830/130828235430-914d6bb6ceddd6713226a1b0f749c17c (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |